What Is 19-nortestosterone caproate

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 14, 2026

Quick Answer: 19-nortestosterone caproate is a synthetic anabolic steroid ester derived from nandrolone, developed in the 1960s but never marketed. It has a half-life of approximately 14 days and was studied for potential use in hormone therapy and performance enhancement.

Key Facts

19-nortestosterone caproate is a derivative of nandrolone, first synthesized in the 1960s
The compound has a molecular weight of 374.53 g/mol and chemical formula C₂₃H₃₄O₃
It features a caproate ester attached at the 17β position, extending its release duration
Animal studies in 1963 showed sustained anabolic effects over two weeks post-injection
Despite promising early data, it was never approved for human use or commercialized

Overview

19-nortestosterone caproate is a long-acting anabolic steroid ester derived from nandrolone, also known as 19-nortestosterone. It belongs to a class of modified testosterone analogs designed to enhance muscle growth while minimizing androgenic side effects.

Developed during the peak of steroid research in the 1960s, this compound was studied for potential medical and performance applications. Although never marketed, it remains of interest in pharmacological and forensic science contexts due to its structural and functional properties.

Synthetic origin: First prepared in 1961 by chemists at Syntex Corporation as part of a broader effort to optimize nandrolone derivatives for clinical use.
Chemical structure: Features a six-carbon caproate ester chain attached at the 17β-hydroxyl group, increasing lipid solubility and prolonging release.
Pharmacokinetics: After intramuscular injection, it hydrolyzes slowly to release free nandrolone, with a plasma half-life estimated at 14 days.
Anabolic ratio: In rodent assays, it demonstrated an anabolic:androgenic ratio of 10:1, significantly higher than testosterone propionate’s 1:1 ratio.
Research status: Limited to animal trials and in vitro studies; no human clinical trials were completed, and it was never approved by the FDA or EMA.

How It Works

The mechanism of action of 19-nortestosterone caproate revolves around its conversion to active nandrolone and subsequent binding to androgen receptors in target tissues. Its esterification allows for depot storage in fat, enabling gradual release.

Hydrolysis: After injection, esterases in the blood and liver cleave the caproate group, releasing active nandrolone over a period of up to two weeks.
Receptor binding: Free nandrolone binds to androgen receptors in muscle and bone, stimulating protein synthesis and promoting tissue growth.
Reduced androgenicity: Lacking the C19 methyl group, it shows lower affinity for 5α-reductase, reducing conversion to potent androgens like DHT.
Glucocorticoid antagonism: Demonstrates mild anti-catabolic effects by blocking cortisol receptors, preserving muscle during caloric deficit.
Hepatic impact: Unlike oral steroids, it is not 17α-alkylated, resulting in minimal liver toxicity in animal models.
Detection window: Metabolites can be detected in urine for up to 18 months, making it a target in anti-doping screening.

Comparison at a Glance

The following table compares 19-nortestosterone caproate with related compounds in terms of half-life, potency, and clinical status:

Compound	Half-Life (days)	Anabolic:Androgenic Ratio	Approved Uses	Year First Synthesized
19-nortestosterone caproate	14	10:1	None	1961
Nandrolone decanoate	7–8	10:1	Anemia, osteoporosis	1960
Testosterone enanthate	4–5	1:1	Hypogonadism	1952
Trenbolone hexahydrobenzylcarbonate	6–8	12:1	Veterinary only	1960s
Methandrostenolone (Dianabol)	0.5	2:1	Discontinued	1958

While nandrolone decanoate reached clinical use, 19-nortestosterone caproate remained experimental. Its longer half-life suggests potential for less frequent dosing, but lack of human safety data prevented development. The compound’s high anabolic ratio and low hepatotoxicity profile make it a subject of ongoing forensic and biochemical research.

Why It Matters

Though never commercialized, 19-nortestosterone caproate contributes to understanding steroid pharmacology and informs modern drug design. Its properties highlight the balance between efficacy, safety, and regulatory feasibility in hormone therapy.

Doping control: Its long detection window aids anti-doping agencies in identifying illicit steroid use, even after extended periods.
Therapeutic potential: Could inspire future long-acting anabolic agents for treating muscle wasting in cancer or HIV patients.
Structural insight: Demonstrates how ester modification extends half-life without increasing toxicity.
Forensic significance: Serves as a reference compound in mass spectrometry for identifying unknown steroid metabolites.
Historical context: Reflects the ambitious steroid research era of the 1960s, when pharmaceutical companies explored hundreds of analogs.
Legal status: Classified as a Schedule III controlled substance in the U.S., making unauthorized possession or distribution illegal.

While 19-nortestosterone caproate never reached the market, its legacy endures in both medical science and regulatory frameworks. It exemplifies how experimental compounds can shape future innovations despite never becoming approved therapies.